Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

The rise of ultra-thin bodies in Hollywood, fueled by the popularity of weight loss medications, marks a dramatic shift in ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...

An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.

Dr. Karan Rajan responds to Oprah Winfrey's insights on thin people, highlighting the complex biology behind obesity, beyond just willpower.

New research highlights the potential of the protein BCL6 in preserving muscle mass, especially when used with popular weight ...

The protein BCL6 can help in maintaining muscle mass while losing fat. The new study was conducted by researchers from the ...

Media maven Oprah Winfrey stirred controversy during a recent “The Oprah Podcast” episode with Yale University obesity medicine physician Dr.